tralokinumab
leo pharma
['ecztend', 'tralokinumab', 'adbry', 'leo pharma']
leo pharma presents new adbry (tralokinumab-ldrm) data in adolescent population from ecztra 6 and ecztend trials at aad 2023 annual meeting 
Breaking news from Business Wire